WuXi Biologics
Offering End-to-End Solutions
WuXi AppTec is excited to participate in the Alzheimer’s Association International Conference (AAIC) 2025, taking place July 27–31 at the Metro Toronto Convention Centre in Toronto, Canada. This global forum brings together leading researchers, clinicians, and dementia experts to share breakthroughs in Alzheimer’s and related dementia science.
At WuXi AppTec, we support dementia research with integrated R&D services tailored to the needs of neurodegenerative disease programs. Our offerings include high-throughput screening of compound libraries, biomarker discovery, ADME/PK studies, and in vivo preclinical models of neurodegeneration. We partner with clients to advance candidates from early discovery through IND-enabling studies, helping accelerate therapeutic innovation in the fight against dementia.
To schedule a dedicated meeting with our team, please fill out the form on the right.